SUPRANE Side Effects

7001069-0 | Cardiac Arrest
on Sep 09, 2010 Male patient from FRANCE , 49 years of age, weighting 156.5 lb, was treated with Suprane (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?). Suprane dosage: . During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), SUFENTA PRESERVATIVE FREE (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ), ATRACURIUM (View Atracurium Review and Atracurium Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

7001056-2 | Cardiac Arrest
Patient was taking Suprane (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?) on Sep 09, 2010 from FRANCE Additional patient health information: Male patient , 55 years of age, weighting 220.5 lb, . Suprane dosage: . During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), SUFENTA PRESERVATIVE FREE (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ), ATRACURIUM (View Atracurium Review and Atracurium Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), KAYEXALATE (View Kayexalate Review and Kayexalate Label ), SIMULECT (View Simulect Review and Simulect Label ).

6971589-3 | Cardiac Arrest
Adverse event was reported on Sep 01, 2010 by a Male patient taking Suprane (View Usage) (Dosage: ) . Location: FRANCE , 55 years of age, weighting 220.5 lb, After Suprane was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?). During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), SUFENTA PRESERVATIVE FREE (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ), ATRACURIUM (View Atracurium Review and Atracurium Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), KAYEXALATE (View Kayexalate Review and Kayexalate Label ), SIMULECT (View Simulect Review and Simulect Label ).

6971450-4 | Cardiac Arrest
on Sep 01, 2010 Male patient from FRANCE , 49 years of age, weighting 156.5 lb, was treated with Suprane (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?). Suprane dosage: . During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), SUFENTA PRESERVATIVE FREE (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ), ATRACURIUM (View Atracurium Review and Atracurium Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).


6810586-5 | Oliguria, Renal Failure Acute, Rheumatoid Arthritis
on Jun 23, 2010 Female patient from FRANCE , 78 years of age, was diagnosed with anaesthesia procedure and was treated with Suprane (View Usage). Patient had the following side effects: oliguria, renal failure acute, rheumatoid arthritis (What is rheumatoid arthritis?). Suprane dosage: . During the same period patient was treated with SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), PROPOFOL (View Propofol Review and Propofol Label ), ATRACURIUM (View Atracurium Review and Atracurium Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), NAROPIN (View Naropin Review and Naropin Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), ACUPAN (View Acupan Review and Acupan Label ), DROPERIDOL (View Droperidol Review and Droperidol Label ). Patient was hospitalized.

6801927-3 | Haematuria, Oliguria, Renal Failure Acute
Patient was taking Suprane (View Usage). After Suprane was administered, patient had the following side effects: haematuria, oliguria, renal failure acute on Jun 21, 2010 from FRANCE Additional patient health information: Female patient , 49 years of age, . Suprane dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), ATRACURIUM (View Atracurium Review and Atracurium Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), NORMACOL (View Normacol Review and Normacol Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ACUPAN (View Acupan Review and Acupan Label ), POVIDONE IODINE (View Povidone-iodine Review and Povidone-iodine Label ), POVIDONE IODINE (View Povidone-iodine Review and Povidone-iodine Label ). Patient was hospitalized.

6784674-6 | Acute Pulmonary Oedema, Haematuria, Oliguria, Renal Failure Acute
Adverse event was reported on Jun 09, 2010 by a Female patient taking Suprane (View Usage) (Dosage: ) was diagnosed with hysterectomy (What is hysterectomy?), cystoscopy, ureteroscopy and. Location: FRANCE , 47 years of age, Patient experienced the following unwanted or unexpected effects: acute pulmonary oedema, haematuria, oliguria, renal failure acute. During the same period patient was treated with SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ). Patient was hospitalized.

6722506-2 | Hypotension, Product Colour Issue, Product Deposit
on Apr 19, 2010 Male patient from PORTUGAL , 73 years of age, was treated with Suprane (View Usage). Patient had the following side effects: hypotension, product colour issue, product deposit. Suprane dosage: .

6702752-4 | Hypotension, Product Colour Issue, Product Deposit
on Apr 19, 2010 Male patient from PORTUGAL , 73 years of age, was treated with Suprane (View Usage). After Suprane was administered, patient had the following side effects: hypotension, product colour issue, product deposit. Suprane dosage: .

6681870-3 | Liver Injury
Patient was taking Suprane (View Usage). Patient experienced the following unwanted or unexpected effects: liver injury on Mar 24, 2010 from AUSTRALIA Additional patient health information: Female patient , 51 years of age, . Suprane dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), PROPOFOL (View Propofol Review and Propofol Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), MORPHINE (View Morphine Review and Morphine Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6662258-8 | Hepatic Enzyme Increased, Hepatitis Cholestatic
Adverse event was reported on Mar 24, 2010 by a Female patient taking Suprane (View Usage) (Dosage: ) . Location: AUSTRALIA , 77 years of age, weighting 154.3 lb, Patient had the following side effects: hepatic enzyme increased, hepatitis cholestatic. During the same period patient was treated with DALTEPARIN (View Dalteparin Review and Dalteparin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), KEFLIN (View Keflin Review and Keflin Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ).

6662194-7 | Liver Injury
on Mar 24, 2010 Female patient from AUSTRALIA , 51 years of age, was treated with Suprane (View Usage). After Suprane was administered, patient had the following side effects: liver injury. Suprane dosage: . During the same period patient was treated with FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), PROPOFOL (View Propofol Review and Propofol Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ). Patient was hospitalized.

6653312-5 | Epilepsy, Intracranial Pressure Increased, Somnolence
on Mar 18, 2010 Male patient from UNITED KINGDOM , child 11 years of age, was treated with Suprane (View Usage). Patient experienced the following unwanted or unexpected effects: epilepsy (What is epilepsy?), intracranial pressure increased, somnolence. Suprane dosage: . Patient was hospitalized.

6634513-9 | Hepatic Failure, Hepatitis, Hepatotoxicity
Patient was taking Suprane (View Usage). Patient had the following side effects: hepatic failure, hepatitis (What is hepatitis?), hepatotoxicity on Mar 04, 2010 from AUSTRALIA Additional patient health information: Female patient , 74 years of age, . Suprane dosage: .

6570792-4 | Hepatitis
Adverse event was reported on Jan 25, 2010 by a Male patient taking Suprane (View Usage) (Dosage: ) was diagnosed with inguinal hernia repair, hypercholesterolaemia, mood altered, alopecia and. Location: GERMANY , 60 years of age, weighting 127.9 lb, After Suprane was administered, patient had the following side effects: hepatitis (What is hepatitis?). During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), HYPERICUM EXTRACT (View Hypericum Extract Review and Hypericum Extract Label ), PROPECIA (View Propecia Review and Propecia Label ), ATRACURIUM (View Atracurium Review and Atracurium Label ), VALERIAN EXTRACT (View Valerian Extract Review and Valerian Extract Label ). Patient was hospitalized.

6526087-8 | Acute Respiratory Distress Syndrome, Cytolytic Hepatitis, Pneumonia, Septic Shock, Urinary Tract Infection
on Dec 14, 2009 Male patient from FRANCE , 71 years of age, weighting 187.4 lb, was diagnosed with anaesthesia and was treated with Suprane (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, cytolytic hepatitis, pneumonia (What is pneumonia?), septic shock, urinary tract infection (What is urinary tract infection?). Suprane dosage: . During the same period patient was treated with NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), OXYGEN (View Oxygen Review and Oxygen Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), HYPNOVEL (View Hypnovel Review and Hypnovel Label ), NIMBEX (View Nimbex Review and Nimbex Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), CEFOXITIN (View Cefoxitin Review and Cefoxitin Label ). Patient was hospitalized.

6519612-4 | Acute Respiratory Distress Syndrome, Cytolytic Hepatitis, Pneumonia, Septic Shock, Urinary Tract Infection
on Dec 14, 2009 Male patient from FRANCE , 71 years of age, weighting 187.4 lb, was diagnosed with anaesthesia and was treated with Suprane (View Usage). Patient had the following side effects: acute respiratory distress syndrome, cytolytic hepatitis, pneumonia (What is pneumonia?), septic shock, urinary tract infection (What is urinary tract infection?). Suprane dosage: . During the same period patient was treated with NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), OXYGEN (View Oxygen Review and Oxygen Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), HYPNOVEL (View Hypnovel Review and Hypnovel Label ), NIMBEX (View Nimbex Review and Nimbex Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), CEFOXITIN (View Cefoxitin Review and Cefoxitin Label ). Patient was hospitalized.

6517032-X | Acute Respiratory Distress Syndrome, Cytolytic Hepatitis, Pneumonia, Septic Shock, Urinary Tract Infection
Patient was taking Suprane (View Usage). After Suprane was administered, patient had the following side effects: acute respiratory distress syndrome, cytolytic hepatitis, pneumonia (What is pneumonia?), septic shock, urinary tract infection (What is urinary tract infection?) on Dec 14, 2009 from FRANCE Additional patient health information: Male patient , 71 years of age, weighting 187.4 lb, was diagnosed with anaesthesia and. Suprane dosage: . During the same period patient was treated with NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), OXYGEN (View Oxygen Review and Oxygen Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), HYPNOVEL (View Hypnovel Review and Hypnovel Label ), NIMBEX (View Nimbex Review and Nimbex Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), CEFOXITIN (View Cefoxitin Review and Cefoxitin Label ). Patient was hospitalized.

6509152-0 | Bronchospasm, Rash
Adverse event was reported on Dec 16, 2009 by a Male patient taking Suprane (View Usage) (Dosage: ) was diagnosed with antibiotic prophylaxis, procedural pain and. Location: FRANCE , 17 years of age, Patient experienced the following unwanted or unexpected effects: bronchospasm, rash (What is rash?). During the same period patient was treated with AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), PROPOFOL (View Propofol Review and Propofol Label ), ULTIVA (View Ultiva Review and Ultiva Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ).

6483243-5 | Cytolytic Hepatitis
on Nov 30, 2009 Male patient from FRANCE , 71 years of age, was treated with Suprane (View Usage). Patient had the following side effects: cytolytic hepatitis. Suprane dosage: . During the same period patient was treated with NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), OXYGEN (View Oxygen Review and Oxygen Label ). Patient was hospitalized.

6448876-0 | Bladder Spasm, Cystostomy, Dizziness, Haematuria, Haemorrhage, Nausea, Pyrexia, Tachycardia
on Sep 26, 2008 Female patient from UNITED STATES , 45 years of age, weighting 204.0 lb, was diagnosed with maintenance of anaesthesia, anaesthesia reversal, medical diet, prophylaxis of nausea and vomiting and was treated with Suprane (View Usage). After Suprane was administered, patient had the following side effects: bladder spasm, cystostomy, dizziness (What is dizziness?), haematuria, haemorrhage, nausea (What is nausea?), pyrexia, tachycardia. Suprane dosage: 4.4 Pct; Continuous; Endtr. During the same period patient was treated with FENTANYL CITRATE (650 Ug; Prn; Iv) (View Fentanyl Citrate Review and Fentanyl Citrate Label ), NEOSTIGMINE METHYLSULATE (0.2 Mg; Once; Iv) (View Neostigmine Methylsulate Review and Neostigmine Methylsulate Label ), DILAUDID (2 Mg; Once; Iv) (View Dilaudid Review and Dilaudid Label ), MULTIVITAMIN WITH IRON (1, Every Day; Po) (View Multivitamin With Iron Review and Multivitamin With Iron Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), VERSED (View Versed Review and Versed Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ). Patient was hospitalized.

6434061-5 | Anaphylactic Shock
Patient was taking Suprane (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock on Nov 02, 2009 from FRANCE Additional patient health information: Male patient , 60 years of age, was diagnosed with anaesthesia and. Suprane dosage: . During the same period patient was treated with SUCCINYLCHOLINE CHLORIDE (View Succinylcholine Chloride Review and Succinylcholine Chloride Label ), PROPOFOL (View Propofol Review and Propofol Label ), REMIFENTANIL (View Remifentanil Review and Remifentanil Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ). Patient was hospitalized.

6415852-3 | Grand Mal Convulsion
Adverse event was reported on Oct 16, 2009 by a Female patient taking Suprane (View Usage) (Dosage: ) was diagnosed with convulsion, type 2 diabetes mellitus and. Location: SOUTH AFRICA , 22 years of age, weighting 136.7 lb, Patient had the following side effects: grand mal convulsion. During the same period patient was treated with KYTRIL (View Kytril Review and Kytril Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), MORPHINE (View Morphine Review and Morphine Label ), ULTIVA (View Ultiva Review and Ultiva Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), MEFOXIN (View Mefoxin Review and Mefoxin Label ).

6344570-5 | Alveolitis, Cardio-respiratory Arrest, Cough, Dyspnoea, Haemoptysis, Hypoxia, Respiratory Distress
on Aug 28, 2009 Male patient from BELGIUM , 16 years of age, weighting 143.3 lb, was diagnosed with anaesthesia, appendicitis (What is appendicitis?), pain (What is pain?), neuromuscular blockade and was treated with Suprane (View Usage). After Suprane was administered, patient had the following side effects: alveolitis, cardio-respiratory arrest, cough, dyspnoea, haemoptysis, hypoxia, respiratory distress. Suprane dosage: . During the same period patient was treated with NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), AUGMENTIN /SCH/ (View Augmentin /sch/ Review and Augmentin /sch/ Label ), BUSCOPAN (View Buscopan Review and Buscopan Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), NIMBEX (View Nimbex Review and Nimbex Label ). Patient was hospitalized.

6334867-7 | Alveolitis, Cardio-respiratory Arrest, Cough, Dyspnoea, Haemoptysis, Hypoxia, Respiratory Distress
on Aug 24, 2009 Male patient from BELGIUM , 16 years of age, weighting 143.3 lb, was diagnosed with anaesthesia, appendicitis (What is appendicitis?), pain (What is pain?) and was treated with Suprane (View Usage). Patient experienced the following unwanted or unexpected effects: alveolitis, cardio-respiratory arrest, cough, dyspnoea, haemoptysis, hypoxia, respiratory distress. Suprane dosage: . During the same period patient was treated with NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), AUGMENTIN /SCH/ (View Augmentin /sch/ Review and Augmentin /sch/ Label ), BUSCOPAN (View Buscopan Review and Buscopan Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ).

6326718-1 | Alveolitis, Cough, Haemoptysis, Respiratory Distress
Patient was taking Suprane (View Usage). Patient had the following side effects: alveolitis, cough, haemoptysis, respiratory distress on Aug 14, 2009 from BELGIUM Additional patient health information: Male patient , 16 years of age, was diagnosed with anaesthesia, appendicectomy and. Suprane dosage: . During the same period patient was treated with NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ).

6307992-4 | Device Failure, Unwanted Awareness During Anaesthesia
Adverse event was reported on Aug 04, 2009 by a Female patient taking Suprane (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: UNITED KINGDOM , 40 years of age, After Suprane was administered, patient had the following side effects: device failure, unwanted awareness during anaesthesia.

6299300-2 | Acute Hepatic Failure, Hepatic Necrosis
on Jul 29, 2009 Female patient from NEW ZEALAND , 17 years of age, was treated with Suprane (View Usage). Patient experienced the following unwanted or unexpected effects: acute hepatic failure, hepatic necrosis. Suprane dosage: .

6239641-8 | Acute Hepatic Failure
on Jun 10, 2009 Female patient from NEW ZEALAND , 17 years of age, was treated with Suprane (View Usage). Patient had the following side effects: acute hepatic failure. Suprane dosage: .

6235143-3 | Bronchospasm, Circulatory Collapse, Haemodynamic Instability
Patient was taking Suprane (View Usage). After Suprane was administered, patient had the following side effects: bronchospasm, circulatory collapse, haemodynamic instability on Jun 11, 2009 from FRANCE Additional patient health information: Male patient , 41 years of age, was diagnosed with infection prophylaxis and. Suprane dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), SUFENTANIL (View Sufentanil Review and Sufentanil Label ), NIMBEX (View Nimbex Review and Nimbex Label ), KEFANDOL (View Kefandol Review and Kefandol Label ). Patient was hospitalized.

6215241-0 | Bradycardia, Cardiac Arrest, Device Malfunction, Overdose
Adverse event was reported on May 27, 2009 by a Female patient taking Suprane (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: FRANCE , 21 years of age, Patient experienced the following unwanted or unexpected effects: bradycardia, cardiac arrest (What is cardiac arrest?), device malfunction, overdose. During the same period patient was treated with HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), NIMBEX (View Nimbex Review and Nimbex Label ), OXYGEN (View Oxygen Review and Oxygen Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ).

6213650-7 | Acidosis, Acute Hepatic Failure, Cardio-respiratory Arrest, Hypoglycaemia, Hypotension, Thrombocytopenia
on May 29, 2009 Female patient from AUSTRALIA , 66 years of age, was diagnosed with anaesthesia and was treated with Suprane (View Usage). Patient had the following side effects: acidosis, acute hepatic failure, cardio-respiratory arrest, hypoglycaemia, hypotension, thrombocytopenia. Suprane dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6208283-2 | Bradycardia, Cardiac Arrest, Device Malfunction, Overdose
on May 20, 2009 Female patient from FRANCE , 20 years of age, was diagnosed with anaesthesia and was treated with Suprane (View Usage). After Suprane was administered, patient had the following side effects: bradycardia, cardiac arrest (What is cardiac arrest?), device malfunction, overdose. Suprane dosage: .

6199681-4 | Blood Pressure Decreased, Carbon Monoxide Poisoning, Device Interaction, Oxygen Saturation Decreased
Patient was taking Suprane (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, carbon monoxide poisoning (What is carbon monoxide poisoning?), device interaction, oxygen saturation decreased on May 15, 2009 from UNITED STATES Additional patient health information: Female patient , child 2 years of age, weighting 35.27 lb, was diagnosed with induction of anaesthesia and. Suprane dosage: . During the same period patient was treated with SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), OXYGEN (View Oxygen Review and Oxygen Label ), NEUROMUSCULAR BLOCKADE (View Neuromuscular Blockade Review and Neuromuscular Blockade Label ).

6197093-0 | Acidosis, Acute Hepatic Failure, Cardio-respiratory Arrest, Hypoglycaemia, Hypotension, Thrombocytopenia
Adverse event was reported on May 11, 2009 by a Female patient taking Suprane (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: AUSTRALIA , 66 years of age, Patient had the following side effects: acidosis, acute hepatic failure, cardio-respiratory arrest, hypoglycaemia, hypotension, thrombocytopenia. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6195948-4 |
on May 07, 2009 Male patient from UNITED STATES , 61 years of age, was treated with Suprane (View Usage). . Suprane dosage: . During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ), ETHANOL (View Ethanol Review and Ethanol Label ).

6190898-1 | Acute Hepatic Failure
on May 10, 2009 Female patient from NEW ZEALAND , 17 years of age, was treated with Suprane (View Usage). Patient experienced the following unwanted or unexpected effects: acute hepatic failure. Suprane dosage: .

6190894-4 | Chills, Flushing, Hypersensitivity, Malaise, Nausea, Tachycardia
Patient was taking Suprane (View Usage). Patient had the following side effects: chills, flushing, hypersensitivity, malaise, nausea (What is nausea?), tachycardia on May 05, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 32 years of age, . Suprane dosage: .

6157137-9 | Compartment Syndrome, Hyperthermia Malignant
Adverse event was reported on Apr 07, 2009 by a Male patient taking Suprane (View Usage) (Dosage: ) was diagnosed with anaesthesia, analgesia, sedation and. Location: FRANCE , 22 years of age, After Suprane was administered, patient had the following side effects: compartment syndrome, hyperthermia malignant. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), SUCCINYLCHOLINE CHLORIDE (View Succinylcholine Chloride Review and Succinylcholine Chloride Label ), SUFENTA PRESERVATIVE FREE (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ), MORPHINE (View Morphine Review and Morphine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), HYPNOVEL (View Hypnovel Review and Hypnovel Label ).

6152149-3 | Accidental Exposure, Hepatic Enzyme Increased, Hepatitis
on Apr 02, 2009 Female patient from GERMANY , 52 years of age, weighting 123.5 lb, was diagnosed with accidental exposure, menopause (What is menopause?) and was treated with Suprane (View Usage). Patient experienced the following unwanted or unexpected effects: accidental exposure, hepatic enzyme increased, hepatitis (What is hepatitis?). Suprane dosage: . During the same period patient was treated with SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), ISOFLURANE (View Isoflurane Review and Isoflurane Label ), ENFLURAN (View Enfluran Review and Enfluran Label ), PHYTO STROL (View Phyto-strol Review and Phyto-strol Label ).

6150744-9 | Anaphylactic Shock
on Mar 30, 2009 Female patient from FRANCE , 28 years of age, was diagnosed with induction of anaesthesia and was treated with Suprane (View Usage). Patient had the following side effects: anaphylactic shock. Suprane dosage: . During the same period patient was treated with SUFENTA PRESERVATIVE FREE (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ).

6148264-0 | Increased Upper Airway Secretion
Patient was taking Suprane (View Usage). After Suprane was administered, patient had the following side effects: increased upper airway secretion on Mar 31, 2009 from UNITED STATES Additional patient health information: Female patient , 35 years of age, was diagnosed with anaesthesia, appendicectomy and. Suprane dosage: .

6148249-4 | Increased Upper Airway Secretion
Adverse event was reported on Mar 31, 2009 by a Male patient taking Suprane (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: UNITED STATES , 16 years of age, Patient experienced the following unwanted or unexpected effects: increased upper airway secretion.

6148219-6 | Increased Upper Airway Secretion
on Mar 31, 2009 Female patient from UNITED STATES , 36 years of age, was diagnosed with anaesthesia and was treated with Suprane (View Usage). Patient had the following side effects: increased upper airway secretion. Suprane dosage: .

6137845-6 | Hepatic Failure, Malaise, Red Blood Cell Count Decreased
on Mar 19, 2009 Female patient from AUSTRALIA , 65 years of age, was diagnosed with anaesthesia and was treated with Suprane (View Usage). After Suprane was administered, patient had the following side effects: hepatic failure, malaise, red blood cell count decreased. Suprane dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6099234-2 | Bronchospasm, Rash Erythematous
Patient was taking Suprane (View Usage). Patient experienced the following unwanted or unexpected effects: bronchospasm, rash erythematous on Feb 23, 2009 from FRANCE Additional patient health information: Male patient , 17 years of age, was diagnosed with anaesthesia and. Suprane dosage: . During the same period patient was treated with SUFENTA PRESERVATIVE FREE (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ).

6055032-7 | Increased Upper Airway Secretion
Adverse event was reported on Jan 19, 2009 by a Female patient taking Suprane (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: UNITED STATES , 36 years of age, Patient had the following side effects: increased upper airway secretion.

6055031-5 | Increased Upper Airway Secretion
on Jan 19, 2009 Male patient from UNITED STATES , 16 years of age, was diagnosed with anaesthesia and was treated with Suprane (View Usage). After Suprane was administered, patient had the following side effects: increased upper airway secretion. Suprane dosage: .

6055016-9 | Increased Upper Airway Secretion
on Jan 19, 2009 Female patient from UNITED STATES , 35 years of age, was diagnosed with anaesthesia, appendicectomy and was treated with Suprane (View Usage). Patient experienced the following unwanted or unexpected effects: increased upper airway secretion. Suprane dosage: .

5960206-7 | Bladder Spasm, Cystostomy, Dizziness, Haematuria, Haemorrhage, Nausea, Pyrexia, Tachycardia
Patient was taking Suprane (View Usage). Patient had the following side effects: bladder spasm, cystostomy, dizziness (What is dizziness?), haematuria, haemorrhage, nausea (What is nausea?), pyrexia, tachycardia on Sep 26, 2008 from UNITED STATES Additional patient health information: Female patient , 45 years of age, weighting 204.0 lb, was diagnosed with maintenance of anaesthesia, anaesthesia reversal, medical diet, prophylaxis of nausea and vomiting and. Suprane dosage: 4.4 Pct;continuous; Endtr. During the same period patient was treated with FENTANYL CITRATE (650 Ug;prn;iv) (View Fentanyl Citrate Review and Fentanyl Citrate Label ), NEOSTIGMINE METHYLSULFATE (0.2 Mg;once;iv) (View Neostigmine Methylsulfate Review and Neostigmine Methylsulfate Label ), DILAUDID (2 Mg;once;iv) (View Dilaudid Review and Dilaudid Label ), MULTIVITAMIN WITH IRON (1; Every Day; Po) (View Multivitamin With Iron Review and Multivitamin With Iron Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), VERSED (View Versed Review and Versed Label ). Patient was hospitalized.